Julie Brahmer, MD, talks about the potential impact of immunotherapy in 1st line NSCLC

Описание: During the ASCO meeting, Julie Brahmer, MD, Assistant Professor of Medicine, Johns Hopkins School of Medicine discusses the potential future impact of immunotherapy on how clinicians approach newly diagnosed or 1st line metastatic NSCLC patients